These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 30681985)
1. Kappa opioid signaling in the central nucleus of the amygdala promotes disinhibition and aversiveness of chronic neuropathic pain. Navratilova E; Ji G; Phelps C; Qu C; Hein M; Yakhnitsa V; Neugebauer V; Porreca F Pain; 2019 Apr; 160(4):824-832. PubMed ID: 30681985 [TBL] [Abstract][Full Text] [Related]
2. Small conductance calcium activated potassium (SK) channel dependent and independent effects of riluzole on neuropathic pain-related amygdala activity and behaviors in rats. Thompson JM; Yakhnitsa V; Ji G; Neugebauer V Neuropharmacology; 2018 Aug; 138():219-231. PubMed ID: 29908238 [TBL] [Abstract][Full Text] [Related]
3. Lateralized kappa opioid receptor signaling from the amygdala central nucleus promotes stress-induced functional pain. Nation KM; De Felice M; Hernandez PI; Dodick DW; Neugebauer V; Navratilova E; Porreca F Pain; 2018 May; 159(5):919-928. PubMed ID: 29369967 [TBL] [Abstract][Full Text] [Related]
4. Contribution of AMPA Receptor-Mediated LTD in LA/BLA-CeA Pathway to Comorbid Aversive and Depressive Symptoms in Neuropathic Pain. Jiang H; Liu JP; Xi K; Liu LY; Kong LY; Cai J; Cai SQ; Han XY; Song JG; Yang XM; Wan Y; Xing GG J Neurosci; 2021 Aug; 41(34):7278-7299. PubMed ID: 34272314 [TBL] [Abstract][Full Text] [Related]
5. Sensitization of neurons in the central nucleus of the amygdala via the decreased GABAergic inhibition contributes to the development of neuropathic pain-related anxiety-like behaviors in rats. Jiang H; Fang D; Kong LY; Jin ZR; Cai J; Kang XJ; Wan Y; Xing GG Mol Brain; 2014 Oct; 7():72. PubMed ID: 25277376 [TBL] [Abstract][Full Text] [Related]
6. Selective modulation of tonic aversive qualities of neuropathic pain by morphine in the central nucleus of the amygdala requires endogenous opioid signaling in the anterior cingulate cortex. Navratilova E; Nation K; Remeniuk B; Neugebauer V; Bannister K; Dickenson AH; Porreca F Pain; 2020 Mar; 161(3):609-618. PubMed ID: 31725062 [TBL] [Abstract][Full Text] [Related]
7. Blockade of kappa opioid receptors reduces mechanical hyperalgesia and anxiety-like behavior in a rat model of trigeminal neuropathic pain. Turnes JM; Araya EI; Barroso AR; Baggio DF; Koren LO; Zanoveli JM; Chichorro JG Behav Brain Res; 2022 Jan; 417():113595. PubMed ID: 34592375 [TBL] [Abstract][Full Text] [Related]
8. Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention. Xie JY; De Felice M; Kopruszinski CM; Eyde N; LaVigne J; Remeniuk B; Hernandez P; Yue X; Goshima N; Ossipov M; King T; Streicher JM; Navratilova E; Dodick D; Rosen H; Roberts E; Porreca F Cephalalgia; 2017 Jul; 37(8):780-794. PubMed ID: 28376659 [TBL] [Abstract][Full Text] [Related]
12. Kappa opioid receptor activation decreases inhibitory transmission and antagonizes alcohol effects in rat central amygdala. Gilpin NW; Roberto M; Koob GF; Schweitzer P Neuropharmacology; 2014 Feb; 77():294-302. PubMed ID: 24157490 [TBL] [Abstract][Full Text] [Related]
13. Kappa opioid signaling in the right central amygdala causes hind paw specific loss of diffuse noxious inhibitory controls in experimental neuropathic pain. Phelps CE; Navratilova E; Dickenson AH; Porreca F; Bannister K Pain; 2019 Jul; 160(7):1614-1621. PubMed ID: 30870321 [TBL] [Abstract][Full Text] [Related]
14. 5-HT Ji G; Zhang W; Mahimainathan L; Narasimhan M; Kiritoshi T; Fan X; Wang J; Green TA; Neugebauer V J Neurosci; 2017 Feb; 37(6):1378-1393. PubMed ID: 28011743 [TBL] [Abstract][Full Text] [Related]
15. Dissociating Motivational From Physiological Withdrawal in Alcohol Dependence: Role of Central Amygdala κ-Opioid Receptors. Kissler JL; Walker BM Neuropsychopharmacology; 2016 Jan; 41(2):560-7. PubMed ID: 26105136 [TBL] [Abstract][Full Text] [Related]
16. Multiple sites and actions of gabapentin-induced relief of ongoing experimental neuropathic pain. Bannister K; Qu C; Navratilova E; Oyarzo J; Xie JY; King T; Dickenson AH; Porreca F Pain; 2017 Dec; 158(12):2386-2395. PubMed ID: 28832395 [TBL] [Abstract][Full Text] [Related]
17. Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance. Xu M; Petraschka M; McLaughlin JP; Westenbroek RE; Caron MG; Lefkowitz RJ; Czyzyk TA; Pintar JE; Terman GW; Chavkin C J Neurosci; 2004 May; 24(19):4576-84. PubMed ID: 15140929 [TBL] [Abstract][Full Text] [Related]
18. Kappa opioid receptors in the central amygdala modulate spinal nociceptive processing through an action on amygdala CRF neurons. Ji G; Neugebauer V Mol Brain; 2020 Sep; 13(1):128. PubMed ID: 32948219 [TBL] [Abstract][Full Text] [Related]
19. Long-term synaptic plasticity in the spinal dorsal horn and its modulation by electroacupuncture in rats with neuropathic pain. Xing GG; Liu FY; Qu XX; Han JS; Wan Y Exp Neurol; 2007 Dec; 208(2):323-32. PubMed ID: 17936754 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of mu and kappa opioid antagonists on Fos-like immunoreactivity in extended amygdala. Carr KD; Kutchukhidze N; Park TH Brain Res; 1999 Mar; 822(1-2):34-42. PubMed ID: 10082881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]